Corpus 1,272 assessed · 1,173 scored · 643 reproduced ≥75 · 168 flagged ·∅ 74.1/100

Publications 4 Datasets 392.5k Experiments 4.7k

Explore

Filters: IT ✕ National Institutes of Health ✕ clear all

4 matching publication(s)

Publication	Journal	Year	Score	Verdict
Genomics Define Malignant Transformation in Myeloma Precursor Conditions. PMID 41061199	J Clin Oncol	2025	78	L1 78/100
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma. PMID 33420019	Nat Commun	2021	50	50/100
Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma. ⚑ PMID 31784732	Nat Genet	2019	58	58/100 ⚑
Cell Specific eQTL Analysis without Sorting Cells. PMID 25955312	PLoS Genet	2015	90	L1 90/100

Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

PMID 41061199 · J Clin Oncol · 2025

L1 78/100

Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.

PMID 33420019 · Nat Commun · 2021

50/100

Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma.⚑

PMID 31784732 · Nat Genet · 2019

58/100 ⚑

Cell Specific eQTL Analysis without Sorting Cells.

PMID 25955312 · PLoS Genet · 2015

L1 90/100